Full-Time

Executive Director

Data Engineering, Retail Analytics

Posted on 8/18/2026

Deadline 9/18/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$175.1k - $334.8k/yr

+ Bonus + Commission + Short-term incentive + Equity award

Company Historically Provides H1B Sponsorship

Connecticut, USA + 4 more

More locations: Texas, USA | New York, NY, USA | Woonsocket, RI, USA | Massachusetts, USA

Hybrid

Remote/hybrid arrangements are listed for Woonsocket and the specified states.

Bachelor's, Master's

Category
Data & Analytics (1)
Required Skills
Data Science
Machine Learning
Data Engineering
Data Governance
DevOps

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • The role requires 15+ years of progressive experience in Data Engineering, Software Engineering, Analytics Engineering, or related technology disciplines.
  • The role requires 7+ years of experience leading large engineering organizations through multiple layers of leadership.
  • Candidates must have experience designing and delivering enterprise-scale data platforms, data products, and cloud-native engineering solutions.
  • Candidates must have deep expertise in modern data engineering practices, including data pipelines, distributed processing, cloud platforms, data governance, and platform reliability.
  • Candidates must have demonstrated success partnering with Analytics, Data Science, Product, and business organizations to translate complex business needs into scalable technology solutions.
  • Candidates must have strong experience leading large transformation initiatives, platform modernization efforts, and organizational change.
  • Candidates must be adept at execution and delivery, including strategic planning, roadmap development, and operational management.
  • Candidates must be adept at business intelligence and data-driven decision-making.
  • Candidates must demonstrate mastery of collaboration, stakeholder management, and executive communication.
  • Candidates must demonstrate mastery of problem solving, strategic thinking, and organizational leadership.
  • Candidates must demonstrate mastery of growth mindset principles, with the ability to develop leaders and build high-performing teams.
  • Candidates must have a bachelor's degree in Computer Science, Engineering, Information Systems, Mathematics, Statistics, or a related quantitative field.
Responsibilities
  • Define and execute the data engineering strategy that powers the Retail analytics ecosystem.
  • Lead a large, multi-disciplinary engineering organization focused on designing, building, and scaling enterprise data platforms, AI products, and engineering capabilities.
  • Support Retail Pharmacy, Front Store, Retail Supply Chain, Merchandising, Personalization, Pricing, Marketing, and Operational analytics initiatives.
  • Partner with Data Science, Product, Analytics, Architecture, and business stakeholders to deliver reliable, scalable, cloud-based data solutions.
  • Drive engineering excellence, talent development, platform modernization, and operational rigor while aligning with enterprise technology strategy and business priorities.
Desired Qualifications
  • Experience supporting Retail, Pharmacy, Merchandising, Supply Chain, Marketing, Consumer, or Omnichannel analytics environments.
  • Experience building and scaling enterprise data products, feature stores, real-time data solutions, or analytics enablement platforms.
  • Strong knowledge of cloud-based data ecosystems, platform engineering, DevOps, DataOps, and engineering best practices.
  • Experience enabling AI, machine learning, and advanced analytics solutions through robust data engineering capabilities.
  • Experience operating within a highly regulated, large-scale enterprise environment.
  • Demonstrated ability to influence senior executives and drive alignment across complex organizational structures.
  • A track record of building engineering cultures centered on innovation, accountability, continuous improvement, and delivery excellence.
  • A master's degree in Computer Science, Engineering, Business Administration, Data Science, or a related discipline.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
  • CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.

What critics are saying

  • Reuters said Caremark expects weaker client retention after August 5, 2026 results.
  • Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
  • Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
  • August 5, 2026 results showed all three segments beat revenue expectations.
  • Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.